Vir Biotechnology, Inc. revenue breakdown overview

Vir Biotechnology, Inc. revenue for the last year amounted to 86.18 M USD, the most of which — 86.18 M USD — came from its highest performing source at the moment, Antibody-based Therapies, the year earlier bringing 1.62 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Vir Biotechnology, Inc. 86.18 M USD, and the year before that — 1.62 B USD.